Patterns of recurrence after radiation therapy for high-risk neuroblastoma
Ji Hwan Jo, Seung Do Ahn, Minji Koh, Jong Hoon Kim, Sang-wook Lee, Si Yeol Song, Sang Min Yoon, Young Seok Kim, Su Ssan Kim, Jin-hong Park, Jinhong Jung, Eun Kyung Choi
Radiat Oncol J. 2019;37(3):224-231. Published online 2019 Sep 30 DOI: https://doi.org/10.3857/roj.2019.00353
Citations to this article as recorded by 
Intraoperative Radiation Therapy for Relapsed or Refractory High-Risk Neuroblastoma: A 27-Year Experience
Brianna Conte, Dana L. Casey, Kathryn R. Tringale, Joshua Honeyman, Nicole J.C. Narayan, Michael P. LaQuaglia, Justin Ted Gerstle, Shakeel Modak, Brian H. Kushner, Kim Kramer, Suzanne L. Wolden
Practical Radiation Oncology.2024;[Epub] CrossRef
MYCN Impact on High-Risk Neuroblastoma: From Diagnosis and Prognosis to Targeted Treatment
Damiano Bartolucci, Luca Montemurro, Salvatore Raieli, Silvia Lampis, Andrea Pession, Patrizia Hrelia, Roberto Tonelli
Cancers.2022; 14(18): 4421. CrossRef
Proton Beam Therapy for Children With Neuroblastoma: Experiences From the Prospective KiProReg Registry
Danny Jazmati, Sarina Butzer, Barbara Hero, Dalia Ahmad Khalil, Julien Merta, Christian Bäumer, Gina Plum, Jörg Fuchs, Friederike Koerber, Theresa Steinmeier, Sarah Peters, Jerome Doyen, Theresa Thole, Matthias Schmidt, Christoph Blase, Stephan Tippelt, A
Frontiers in Oncology.2021;[Epub] CrossRef
Chromosome band 11q23 deletion predicts poor prognosis in bone marrow metastatic neuroblastoma patients without MYCN amplification
Zhi‐Xia Yue, Tian‐Yu Xing, Chao Gao, Shu‐Guang Liu, Wen Zhao, Qian Zhao, Xi‐Si Wang, Mei Jin, Xiao‐Li Ma
Cancer Communications.2019; 39(1): 1. CrossRef